Multiple Sclerosis and Other Demyelinating Disorders

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Mental health problems are common in multiple sclerosis (MS). Clinically diagnosable depression occurs in about 50% of patients over their lifetimes, compared with only about 8% for the general population. Anxiety has been less well-studied, but it has also been found to be very common, with most studies suggesting that about 35% of patients experience clinically significant anxiety at any given time. In this article, we review factors that may contribute to anxiety and depression in MS. We also discuss some treatment research and provide guidelines for future investigations that may explore these mental health problems in MS.

Original languageEnglish (US)
Title of host publicationEncyclopedia of Mental Health
Subtitle of host publicationSecond Edition
PublisherElsevier Inc.
Pages169-174
Number of pages6
ISBN (Electronic)9780123970459
ISBN (Print)9780123977533
DOIs
StatePublished - Jan 1 2016

Fingerprint

Demyelinating Diseases
Multiple Sclerosis
Anxiety
Mental Health
Depression
Guidelines
Research
Population
Therapeutics

All Science Journal Classification (ASJC) codes

  • Psychology(all)

Cite this

Arnett, P. A., & Cadden, M. (2016). Multiple Sclerosis and Other Demyelinating Disorders. In Encyclopedia of Mental Health: Second Edition (pp. 169-174). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-397045-9.00127-0
Arnett, Peter Andrew ; Cadden, M. / Multiple Sclerosis and Other Demyelinating Disorders. Encyclopedia of Mental Health: Second Edition. Elsevier Inc., 2016. pp. 169-174
@inbook{b3efb12a38e1438b9ed0d780dd919e42,
title = "Multiple Sclerosis and Other Demyelinating Disorders",
abstract = "Mental health problems are common in multiple sclerosis (MS). Clinically diagnosable depression occurs in about 50{\%} of patients over their lifetimes, compared with only about 8{\%} for the general population. Anxiety has been less well-studied, but it has also been found to be very common, with most studies suggesting that about 35{\%} of patients experience clinically significant anxiety at any given time. In this article, we review factors that may contribute to anxiety and depression in MS. We also discuss some treatment research and provide guidelines for future investigations that may explore these mental health problems in MS.",
author = "Arnett, {Peter Andrew} and M. Cadden",
year = "2016",
month = "1",
day = "1",
doi = "10.1016/B978-0-12-397045-9.00127-0",
language = "English (US)",
isbn = "9780123977533",
pages = "169--174",
booktitle = "Encyclopedia of Mental Health",
publisher = "Elsevier Inc.",
address = "United States",

}

Arnett, PA & Cadden, M 2016, Multiple Sclerosis and Other Demyelinating Disorders. in Encyclopedia of Mental Health: Second Edition. Elsevier Inc., pp. 169-174. https://doi.org/10.1016/B978-0-12-397045-9.00127-0

Multiple Sclerosis and Other Demyelinating Disorders. / Arnett, Peter Andrew; Cadden, M.

Encyclopedia of Mental Health: Second Edition. Elsevier Inc., 2016. p. 169-174.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Multiple Sclerosis and Other Demyelinating Disorders

AU - Arnett, Peter Andrew

AU - Cadden, M.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Mental health problems are common in multiple sclerosis (MS). Clinically diagnosable depression occurs in about 50% of patients over their lifetimes, compared with only about 8% for the general population. Anxiety has been less well-studied, but it has also been found to be very common, with most studies suggesting that about 35% of patients experience clinically significant anxiety at any given time. In this article, we review factors that may contribute to anxiety and depression in MS. We also discuss some treatment research and provide guidelines for future investigations that may explore these mental health problems in MS.

AB - Mental health problems are common in multiple sclerosis (MS). Clinically diagnosable depression occurs in about 50% of patients over their lifetimes, compared with only about 8% for the general population. Anxiety has been less well-studied, but it has also been found to be very common, with most studies suggesting that about 35% of patients experience clinically significant anxiety at any given time. In this article, we review factors that may contribute to anxiety and depression in MS. We also discuss some treatment research and provide guidelines for future investigations that may explore these mental health problems in MS.

UR - http://www.scopus.com/inward/record.url?scp=85043282645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043282645&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-397045-9.00127-0

DO - 10.1016/B978-0-12-397045-9.00127-0

M3 - Chapter

SN - 9780123977533

SP - 169

EP - 174

BT - Encyclopedia of Mental Health

PB - Elsevier Inc.

ER -

Arnett PA, Cadden M. Multiple Sclerosis and Other Demyelinating Disorders. In Encyclopedia of Mental Health: Second Edition. Elsevier Inc. 2016. p. 169-174 https://doi.org/10.1016/B978-0-12-397045-9.00127-0